Patents by Inventor Klaus-Dieter Ramsch

Klaus-Dieter Ramsch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5264446
    Abstract: The invention is directed to the provision of solid pharmaceutical compositions (and methods for their preparation) containing nifidipine crystals with a specific surface area of 1.0 to 4.0 m.sup.2 /g., in admixture with a solid diluent. The said compositions overcome the deficiencies of prior art compositions containing nifidipine, which is known to have effect as a coronary vasodilator.
    Type: Grant
    Filed: June 1, 1992
    Date of Patent: November 23, 1993
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ahmed Hegasy, Klaus-Dieter Ramsch
  • Patent number: 4857312
    Abstract: A sprayable liquid formulation comprising, per 100 ml of the formulation,(a) 0.2 to 5 grams of a dihydropyridine of the formula ##STR1## in which R.sup.1 and R.sup.2 each independently is alkyl with 1 to 10 carbon atoms optionally substituted by alkoxy with 1 to 3 carbon atoms, trifluoromethyl, halogen or N-methyl-N-benzylamino,R.sup.3 is alkyl with 1 to 4 carbon atoms, cyano or hydroxymethyl, andX is a nitro group, one or two chlorine groups or the ring member .dbd.N--O--N.dbd.,(b) 10 to 40 grams of polyethylene glycol with an average molecular weight of 200 to 600,(c) 25 to 60 grams of ethyl alcohol, and(d) 3 to 15 grams of polyvinylpyrrolidine with an average molecular weight of 12000 to 30000.
    Type: Grant
    Filed: March 17, 1988
    Date of Patent: August 15, 1989
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ahmed Hegasy, Klaus-Dieter Ramsch
  • Patent number: 4562069
    Abstract: In the treatment of cardiovascular and coronary disorders by administering to a patent suffering therefrom a solid preparation comprising nifedipine, the improvement which comprises administering such nifedipine in the form of a solid two-phase medicament formulation comprising a nifedipine coprecipitate, in which the nifedipine is present in a non-crystalline form, and crystalline nifedipine, whereby the nifedipine rapidly enters the blood stream in a relatively high concentration which is maintained for a relatively long time.
    Type: Grant
    Filed: May 2, 1984
    Date of Patent: December 31, 1985
    Assignee: Bayer Aktiengesellschaft
    Inventors: Ahmed Hegasy, Roland Rupp, Klaus-Dieter Ramsch, Helmut Luchtenberg
  • Patent number: 4537898
    Abstract: A rapidly absorbable liquid formulation of a dihydropyridine comprising, by weight, about 0.5 to 10 parts of a dihydropyridine of the formula ##STR1## in which R.sub.1 is C.sub.1 -C.sub.4 -alkyl, optionally substituted by C.sub.2 -C.sub.3 -alkoxy,R.sub.2 is C.sub.1 -C.sub.10 -alkyl, optionally substituted by C.sub.1 -C.sub.3 -alkoxy, trifluoromethyl or N-methyl-N-benzylamino,R.sub.3 is C.sub.1 -C.sub.4 -alkyl, cyano or hydroxymethyl, andX is 2- or 3-nitro, 2,3-dichloro or 2,3.dbd.N--O--N.dbd.,20 to 60 parts of a solubilizing agent and 80 to 40 parts of a diluent.
    Type: Grant
    Filed: February 13, 1984
    Date of Patent: August 27, 1985
    Assignee: Bayer Aktiengesellschaft
    Inventors: Dieter Hoff, Klaus-Dieter Ramsch